$4.59
Price
$519M
Market Cap
—
P/E Ratio
11.7
Forward P/E
$-4.49
EPS (TTM)
—
Dividend Yield
$116M
Cash
$990M
Total Debt
113M
Shares Out
$2.10
$10.08
52-Week Range
Institutional Ownership of Evolent Health Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 5.6M | $30M | $18.22 | -74.81% | ||
| 5.5M | $4M | $3.90 | +17.69% |
Trading Activity for Evolent Health Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | NEW | 5.5M | $4M | $3.90 | |
| 2025-Q4 | |||||
| SELL | -1.8% | 5.6M | $22M | $4.31 | |
| 2025-Q3 | |||||
| SELL | -3.2% | 5.7M | $48M | $9.60 | |
| 2025-Q2 | |||||
| BUY | +13.0% | 5.9M | $66M | $9.05 | |
| 2025-Q1 | |||||
| SELL | -4.2% | 5.2M | $49M | $10.00 | |
| 2024-Q4 | |||||
| BUY | +35.5% | 5.4M | $61M | $13.26 | |
| 2024-Q3 | |||||
| SELL | -3.0% | 4.0M | $113M | $26.64 | |
| 2024-Q2 | |||||
| BUY | +26.1% | 4.1M | $79M | $23.75 | |
| 2023-Q4 | |||||
| BUY | +15.1% | 3.3M | $108M | $28.14 | |
| 2023-Q3 | |||||
| BUY | +62.1% | 2.8M | $77M | $27.30 | |
| 2023-Q2 | |||||
| SELL | -21.1% | 1.7M | $53M | $32.13 | |
| 2023-Q1 | |||||
| SELL | -20.6% | 2.2M | $72M | $31.50 | |
| 2022-Q4 | |||||
| BUY | +24.3% | 2.8M | $78M | $27.71 | |
| 2022-Q3 | |||||
| SELL | -63.6% | 2.2M | $81M | $35.24 | |
| 2022-Q2 | |||||
| SELL | -13.9% | 6.2M | $189M | $29.15 | |
| 2022-Q1 | |||||
| SELL | -8.7% | 7.1M | $231M | $24.58 | |
| 2021-Q4 | |||||
| SELL | -0.8% | 7.8M | $217M | $28.55 | |
| 2021-Q3 | |||||
| SELL | -7.7% | 7.9M | $245M | $23.84 | |
| 2020-Q3 | |||||
| BUY | NEW | 8.6M | $106M | $12.43 | |
Insider Trading for Evolent Health Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.